Skip to main content

The Importance of Clinical Trials to Treat Blood Cancer

Recorded on: August 9, 2023

Click Here to Participate

Recorded on: August 9, 2023
0.5 CE Contact hour for nurses available until: May 6, 2025
0.5 CME Credit for physicians available until: May 6, 2025 
Non-interactive recorded webinar  


Target Audience

This activity is intended for oncologists and hematologists, advanced practice providers, and nurses involved in the care of patients in community and academic practices.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Summarize the basics of clinical trials
  • Explain the development and phases of clinical trials
  • Describe disparities in clinical trials
  • Engage patients and caregivers in discussion on risks, benefits, myths and costs of clinical trials
  • Explain how LLS can help locate clinical trials that may be right for your patients


Kelly Laschinger, MSN, RN, CPNP, CPHON
Manager, Clinical Trial Support Center 
The Leukemia & Lymphoma Society
Rye Brook, NY

Steven Tsai, MD, PhD
UCLA Health Cancer Care
Los Angeles, CA

Continuing Education Information

Accreditation, Credit and Support

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc., and The Leukemia & Lymphoma Society.  Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 0.5 contact hour and no contact hour in the area of pharmacology.

Interprofessional Continuing Education (IPCE) Statement

Interprofessional Continuing Education (IPCE) credit

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

This activity is provided by The Leukemia & Lymphoma Society, Medical Learning Institute, Inc. in collaboration with The Association of Community Cancer Centers.

There is no commercial support associated with this CE activity.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: